HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

2-Chloro-deoxyadenosine induces durable complete remission in Castleman's disease but may accelerate its transformation to non-Hodgkin's lymphoma.

Abstract
There is currently no consensus on the best treatment for unresectable hyaline-vascular variant or for multicentric Castleman's disease (MCD), because none of the reported regimens have consistently produced complete response or durable remission in the majority of patients In the present study, we report on the use of 2-CdA (2-chloro-deoxyadenosine) in three patients, two of them with MCD and one with unresectable hyaline-vascular type disease. Relapse-free survival of the responding patients was 24 and 20 months. Later, both patients evolved to non-Hodgkin's lymphoma (NHL) (diffuse large B-cell lymphoma and peripheral T-cell NHL, respectively). 2-CdA typically causes a long-lasting state of immunodeficiency and the profound influence of this drug on the immune system has raised questions concerning the emergence of secondary neoplasms after its use. Therefore, it is reasonable to conclude that: 1) 2-CdA can induce durable complete remission in MCD patients but unfortunately it cannot cure the disease; 2) the possibility that 2-CdA may accelerate the transformation of MCD to NHL cannot be ruled out.
AuthorsGisele W B Colleoni, Luiz Cláudio C Duarte, Fábio Rodrigues Kerbauy, Marcos Lobão, Melissa Palis Yunis, Antonio Correa Alves, Vanda Akiko Ueda Fick de Souza, José Orlando Bordin, José Salvador R de Oliveira
JournalActa oncologica (Stockholm, Sweden) (Acta Oncol) Vol. 42 Issue 7 Pg. 784-7 ( 2003) ISSN: 0284-186X [Print] England
PMID14690166 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Cladribine
Topics
  • Adult
  • Castleman Disease (drug therapy)
  • Cladribine (adverse effects, therapeutic use)
  • Female
  • Humans
  • Lymphoma, Non-Hodgkin (chemically induced)
  • Male
  • Middle Aged
  • Remission Induction
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: